关注
Dong Guo
Dong Guo
在 rx.umaryland.edu 的电子邮件经过验证
标题
引用次数
年份
A genetic-based population PK/PD modeling of methadone in chinese opiate dependence patients
D Guo, Z Tan, X Lou, S Shi, Y Shu, H Zhou, L Yu, H Yang
European Journal of Clinical Pharmacology, 1-14, 2022
12022
A pharmacokinetic and pharmacodynamic investigation of an ε-aminocaproic acid regimen designed for cardiac surgery with cardiopulmonary bypass
ER Strauss, E Dahmane, M Judd, D Guo, B Williams, M Meyer, ...
Journal of cardiothoracic and vascular anesthesia 35 (2), 406-417, 2021
112021
A pharmacokinetic and plasmin-generation pharmacodynamic assessment of a tranexamic acid regimen designed for cardiac surgery with cardiopulmonary bypass
ER Strauss, S Li, R Henderson, R Carpenter, D Guo, K Thangaraju, ...
Journal of Cardiothoracic and Vascular Anesthesia 36 (8), 2473-2482, 2022
52022
A rapid and sensitive LC-MS/MS method for determination of valsartan in human plasma
L LI, Z TAN, Y CHEN, G ZHOU, D GUO, J YAN, G YANG, D OUYANG
Chinese Journal of Clinical Pharmacology and Therapeutics 15 (7), 809, 2010
2010
A simple and sensitive LC-MS/MS method for determination of pravastatin in human plasma
ZR Tan, DS Ouyang, G Zhou, D Guo, Y Chen, C Xiao, L Peng, H Chen, ...
Chinese J New Drugs 17, 1150-3, 2008
9*2008
Advancement of chlorogenic acid in traditional Chinese medicine
LP Wang, D Guo, G Wang, HH Zhou
Lishizhen Med. Mater. Med. Res 22, 961-963, 2011
102011
Aging increases the susceptibility of cisplatin-induced nephrotoxicity
J Wen, M Zeng, Y Shu, D Guo, Y Sun, Z Guo, Y Wang, Z Liu, H Zhou, ...
Age 37, 1-13, 2015
482015
Analysis of Niemann-Pick C1-like 1 (NPC1L1) genetic polymorphisms and haplotypes in Chinese Han population
XY Lou, CZ Qin, MH Bao, DL Hu, F Chen, H Sun, Y Chen, D Guo, ...
Die Pharmazie-An International Journal of Pharmaceutical Sciences 70 (9 …, 2015
42015
Application of a plasmin generation assay to define pharmacodynamic effects of tranexamic acid in women undergoing cesarean delivery
A Miszta, HK Ahmadzia, NLC Luban, S Li, D Guo, LA Holle, JS Berger, ...
Journal of Thrombosis and Haemostasis 19 (1), 221-232, 2021
292021
Cadmium exposure enhances organic cation transporter 2 trafficking to the kidney membrane and exacerbates cisplatin nephrotoxicity
H Yang, J Tang, D Guo, Q Zhao, J Wen, Y Zhang, ON Obianom, S Zhou, ...
Kidney international 97 (4), 765-777, 2020
142020
Cadmium Ion Upregulates the Activity of Human Organic Cation Transporter 2
H Yang, D Guo, Y Shu
The FASEB Journal 31, 819.10-819.10, 2017
22017
Development and validation of a LC–MS/MS method for the determination of ilaprazole enantiomers and its application to a bioequivalence study in healthy Chinese volunteers
Z Tan, Y Wang, Y Chen, D Guo, S Cao, W Zhang, G Zhou, H Zhou, ...
Chromatographia 75, 95-101, 2012
82012
Development and validation of a simple and sensitive liquid chromatography–tandem mass spectrometry method for quantifying trimetazidine in human plasma
G Zhou, ZR Tan, DS Ouyang, Y Chen, D Guo, HT Xie, YZ Liu, L Fan, ...
Clinical and Experimental Pharmacology and Physiology 37 (4), 501-505, 2010
102010
Divergent regulation of OCT and MATE drug transporters by cadmium exposure
H Yang, S Zhou, D Guo, ON Obianom, Q Li, Y Shu
Pharmaceutics 13 (4), 537, 2021
32021
Effect of 393T> C polymorphism of GNAS1 gene on dobutamine response in Chinese healthy subjects
YM Mao, ZQ Liu, BL Chen, D Guo, CT Han, LJ Yang, SY Wang, L Fan, ...
The Journal of Clinical Pharmacology 49 (8), 929-936, 2009
132009
Effect of continuous silymarin administration on oral talinolol pharmacokinetics in healthy volunteers
Y Han, D Guo, Y Chen, ZR Tan, HH Zhou
Xenobiotica 39 (9), 694-699, 2009
542009
Effect of glycyrrhizin on the activity of CYP3A enzyme in humans
JH Tu, YJ He, Y Chen, L Fan, W Zhang, ZR Tan, YF Huang, D Guo, DL Hu, ...
European journal of clinical pharmacology 66 (8), 805-810, 2010
782010
Effect of ondansetron on metformin pharmacokinetics and response in healthy subjects
Q Li, H Yang, D Guo, T Zhang, JE Polli, H Zhou, Y Shu
Drug metabolism and disposition 44 (4), 489-494, 2016
262016
Effect of silymarin on the pharmacokinetics of losartan and its active metabolite E-3174 in healthy Chinese volunteers
Y Han, D Guo, Y Chen, Y Chen, ZR Tan, HH Zhou
European journal of clinical pharmacology 65, 585-591, 2009
892009
Effect of soy extract administration on losartan pharmacokinetics in healthy female volunteers
G Wang, CQ Xiao, Z Li, D Guo, Y Chen, L Fan, RH Qian, XJ Peng, DL Hu, ...
Annals of Pharmacotherapy 43 (6), 1045-1049, 2009
162009
系统目前无法执行此操作,请稍后再试。
文章 1–20